cyclopentane has been researched along with 8-hydroxy-2-(di-n-propylamino)tetralin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bruins Slot, LA; Cussac, D; Grevoz-Barret, C; Lestienne, F; Newman-Tancredi, A | 1 |
1 other study(ies) available for cyclopentane and 8-hydroxy-2-(di-n-propylamino)tetralin
| Article | Year |
|---|---|
F15063, a potential antipsychotic with dopamine D(2)/D(3) receptor antagonist and 5-HT(1A) receptor agonist properties: influence on immediate-early gene expression in rat prefrontal cortex and striatum.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antipsychotic Agents; Benzofurans; Benzylamines; Clozapine; Cyclopentanes; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Gene Expression Regulation; Genes, Immediate-Early; Haloperidol; Male; Mitogen-Activated Protein Kinase 3; Neostriatum; Piperazines; Prefrontal Cortex; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Receptors, Dopamine; Receptors, Dopamine D3; RNA, Messenger; Serotonin 5-HT1 Receptor Agonists; Serotonin Receptor Agonists; Time Factors | 2009 |